ELEVATION ONCOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.85 USD | +6.35% |
|
-4.94% | +616.95% |
| 04-05 | Elevation Oncology, Inc. Announces Management Changes | CI |
| 03-27 | Merrimack Gets $225 Million Milestone Payment, Schedules Meeting For Dissolution Plan | MT |
Chart calendar Elevation Oncology, Inc.
ee0982ce393c3f7a8b4.0nx8M96_ky23xFOFZp3qB090IFJaOXJUao4t0uIeNJk.kR0ldZTc_n6OrxDTPN-1aAs7dhcOUAMbHe0UnotfRPf_Ow11qIjlHNaTAg~0abf9a602879d83ce412ece89d4e32f7
Upcoming events on Elevation Oncology, Inc.
Past events on Elevation Oncology, Inc.
| 2024-04-08 16:30 | American Association for Cancer Research Meeting - Abstract: #3121 |
| 2024-03-11 | Leerink Partners Global Biopharma Conference |
| 2024-03-06 10:30 | TD Cowen Health Care Conference |
| 2023-11-29 08:30 | Piper Sandler Healthcare Conference |
| 2023-11-02 07:30 | Q3 2023 Earnings Release |
| 2023-08-03 07:30 | Q2 2023 Earnings Release |
| 2023-06-16 11:00 | Annual General Meeting |
| 2023-06-03 13:15 | American Society of Clinical Oncology Conference - Abstract # 3016 Poster # 214 |
| 2023-06-01 | American Society of Clinical Oncology Conference |
| 2023-05-15 07:30 | Q1 2023 Earnings Release |
| 2023-04-19 09:00 | American Association for Cancer Research Meeting - Abstract Number: 6300 |
| 2023-04-18 09:00 | American Association for Cancer Research Meeting - Abstract Number: CT229 |
| 2023-04-17 10:15 | American Association for Cancer Research Meeting |
| 2023-04-16 13:30 | American Association for Cancer Research Meeting - Abstract Number: 921 |
| 2023-03-15 08:00 | Oppenheimer Healthcare Conference |
| 2023-03-09 07:30 | Q4 2022 Earnings Release |
| 2023-03-07 12:50 | Cowen Health Care Conference |
| 2023-02-15 16:20 | SVB Securities Global Biopharma Conference |
| 2023-01-12 12:45 | JP Morgan Healthcare Conference |
| 2022-12-06 11:00 | JMP Securities Hematology Oncology Summit |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -32,0 -37,2 13.84% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -32,0 -35,9 10.71% | -94,5 -97,1 2.62% | -40,3 -48,9 17.59% | -40,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -32,0 -36,1 11.29% | -95,1 -97,0 2.02% | -45,7 -49,3 7.34% | -43,9 |
|
Net income Million USD | Released Forecast Spread | -17,3 | -32,0 -36,4 12% | -95,1 -94,3 -0.78% | -45,7 -49,3 7.37% | -45,5 |
|
EPS USD | Released Forecast Spread | -21,8 | -2,64 -2,69 1.79% | -4,09 -3,95 -3.63% | -1,34 -1,46 8.22% | -0,85 |
| Announcement Date | 04/06/21 | 03/03/22 | 09/03/23 | 06/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -9,62 -15,0 35.87% | -17,4 -11,0 -57.85% | -20,1 -18,0 -11.71% | -38,5 -21,0 -83.44% | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -9,62 -13,5 28.93% | -17,4 -12,2 -42.31% | -20,1 -18,3 -9.9% | -38,5 -38,6 0.19% | -18,5 -21,1 12.1% | -16,7 -15,5 -7.69% | -9,83 -11,4 13.45% | -10,9 -11,2 2.19% | -7,95 -11,4 30.59% | -9,57 | -10,2 | -10,9 | -11,6 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,62 -13,8 30.49% | -17,3 -12,9 -33.6% | -19,9 -18,2 -9.29% | -38,8 -38,5 -0.77% | -19,0 -21,0 9.42% | -17,1 -15,8 -8.06% | -10,1 -12,1 16.2% | -10,6 -11,5 7.41% | -7,89 -11,4 30.99% | -9,55 | -10,1 | -10,8 | -11,6 | |
|
Net income Million USD | Released Forecast Spread | -9,62 -14,1 31.55% | -17,3 -12,2 -41.33% | -19,9 -18,2 -9.34% | -38,8 -34,3 -13.38% | -19,0 -18,3 -3.88% | -17,1 -14,1 -21.09% | -10,1 -11,9 15.25% | -10,6 -11,2 5.3% | -7,90 -11,5 31.23% | -9,98 | -10,7 | -11,5 | -12,4 | |
|
EPS USD | Released Forecast Spread | -0,41 -0,60 31.85% | -0,74 -0,53 -40.28% | -0,86 -0,79 -9.15% | -1,67 -1,30 -28.74% | -0,82 -0,73 -11.95% | -0,72 -0,59 -21.35% | -0,37 -0,28 -34.55% | -0,25 -0,32 21.88% | -0,19 -0,24 20.17% | -0,20 | -0,22 | -0,21 | -0,22 | -0,19 |
| Announcement Date | 03/03/22 | 05/05/22 | 04/08/22 | 03/11/22 | 09/03/23 | 15/05/23 | 03/08/23 | 02/11/23 | 06/03/24 | - | - | - | - | - |
More events
Past sector events for Elevation Oncology, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ELEV Stock
- Calendar Elevation Oncology, Inc.
